Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Annual report 2015 – results from 1 January to 31 December, 2015

Investor service announcement no. 1/2016

To: NASDAQ OMX Copenhagen                                                   Hørsholm, Denmark, 2 March, 2016

Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Annual report 2015 – results from 1 January to 31 December, 2015

Veloxis Pharmaceuticals A/S (OMX: VELO) will announce the Annual report 2015 on Wednesday 9 March, 2016. Veloxis’ Management will host an accompanying conference call to discuss the financial results on Wednesday 9 March, 2016 at 3:00 PM CET (Denmark); 2:00 PM GMT (London), 9:00 AM EST (New York),

To access the live conference call, please dial one of the following numbers:

+45 38 32 28 69 Denmark

+44 (0) 20 3427 0503 UK

+1 646 254 3361 USA

Access code 6300894

Following the conference call, a recording will be available on the company’s website http://www.veloxis.com.

For more information, please contact:

Craig A. Collard                                          Johnny Stilou

President & CEO                                         EVP, Chief Financial Officer

Phone: +1 919 524 4317                            Phone: +45 30 53 33 64

Email: cac@veloxis.com                             Email: jst@veloxis.com

Veloxis Pharmaceuticals A/S (VELO)

Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis’ unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.

For further information, please visit www.veloxis.com.

Vedhæftede filer:

020316 Veloxis to host annual report 2015 call.pdf